Clinical Guides
Influenza
A clinically focused, India-facing guide to seasonal influenza diagnosis, risk-based antiviral stewardship, vaccination, infection prevention and escalation of severe respiratory disease.
MedNext Academy | 13 min read
Influenza
A clinically focused, India-facing guide to seasonal influenza diagnosis, risk-based antiviral stewardship, vaccination, infection prevention and escalation of severe respiratory disease.
Summary
Seasonal influenza is an acute respiratory infection caused mainly by influenza A and B viruses. It often begins abruptly with fever, cough, sore throat, myalgia, headache and profound malaise; cough can persist longer than fever. Most otherwise healthy people recover with fluids, rest and symptomatic care, but influenza can cause viral pneumonia, secondary bacterial pneumonia, sepsis, acute respiratory distress syndrome, myocarditis, encephalopathy and worsening of chronic heart, lung, kidney or metabolic disease. The clinical task is to identify severe disease and people likely to benefit from early antiviral treatment, without turning every uncomplicated respiratory illness into an antibiotic prescription.
Clinical influenza-like illness cannot reliably distinguish influenza from SARS-CoV-2, RSV, adenovirus, parainfluenza or rhinovirus, particularly outside an active influenza period. Testing is guided by severity, risk, outbreak investigation and whether the result will change isolation, antiviral or public-health management. A negative rapid test does not overrule severe compatible disease when assay sensitivity or specimen timing is limited.
WHO considers vaccination the best prevention and recommends annual vaccination because immunity declines and viral strains evolve. NCDC's current Indian seasonal-influenza protocol uses clinical categories: uncomplicated Category A illness generally receives symptomatic care rather than oseltamivir, while Category B and C patients are considered for treatment, with empiric therapy not delayed for confirmatory testing when indicated. This guide is educational and does not replace current Indian category definitions, antiviral supply policy, pregnancy care or hospital infection-control protocols.
How Common Is It?
Seasonal influenza circulates globally and may cause epidemics every year. WHO estimates around one billion cases, three to five million severe cases and roughly 0.29 to 0.65 million respiratory deaths annually. These are global estimates, not an India-specific case count. WHO also notes that influenza activity is usually winter-seasonal in temperate areas but can occur more irregularly throughout the year in tropical regions, so calendar expectations should not exclude influenza in India.
Reported numbers depend on healthcare attendance, laboratory capacity, sentinel surveillance, testing criteria, circulating strains and whether data count influenza-like illness, severe acute respiratory infection or laboratory-confirmed influenza. A state line list does not capture every household case, while a laboratory positivity rate does not measure community incidence without a denominator. The NCDC seasonal-influenza page provides year-wise state and Union Territory case and death information and laboratory resources, but numbers change and should be retrieved from the current official surveillance source rather than copied into a static guide.
Burden is disproportionately serious in young children, older adults, pregnant people, people with chronic disease and immune suppression. WHO notes that most deaths in children under five from influenza-related lower respiratory tract infection occur in developing countries, an equity signal rather than a claim about any one Indian hospital. For clinical care, severity, risk factors, oxygenation and progression matter more than population incidence. For public health, vaccination coverage, access to antivirals and early warning from surveillance are more informative than uncontextualised annual totals.
Risk Factors
Severe influenza is more likely in pregnant people, children under five years, adults aged 65 years and over, people with chronic heart, lung, kidney, liver, neurological or metabolic disease, immune suppression, severe obesity and residents of long-term-care or other congregate settings. WHO specifically identifies pregnancy, young children, older age, chronic illnesses, chemotherapy and immune suppression as groups who need prompt medical attention or antiviral consideration when ill. Risk is cumulative: a child with asthma, an older adult with heart failure and a pregnant person with diabetes each need a lower threshold for assessment.
Exposure risk rises in crowded indoor settings, households, hostels, schools, hospitals, care homes and workplaces with poor sick-leave options. Influenza spreads through infectious droplets at close proximity and through contaminated hands, so ventilation, cough etiquette, hand hygiene and staying home while acutely ill matter. Risk communication must avoid implying that a patient caused infection through poor hygiene. Vaccine mismatch, waning immunity and no prior vaccination can increase susceptibility, but vaccination can still reduce severe outcomes even when the match is imperfect.
Drug and clinical history affect antiviral decisions. Renal dysfunction requires dose review for oseltamivir. Drug interactions, swallowing ability, vomiting, neuropsychiatric history and previous adverse effects should be documented. Bacterial co-infection risk rises with severe pneumonia, chronic lung disease and clinical deterioration after initial improvement, but purulent sputum alone does not prove bacterial infection. Routine antibiotics for uncomplicated viral influenza create antimicrobial harm and resistance. A person with new chest pain, syncope, severe myalgia or neurological symptoms needs assessment for complications rather than an assumption of routine flu.
Diagnosis
History
Document sudden fever or feverishness, cough, sore throat, runny nose, headache, myalgia, fatigue, dyspnoea, chest pain, vomiting or diarrhoea, onset date, contact and travel exposures, outbreak setting, vaccination history and prior antiviral use. Ask about pregnancy, age, chronic disease, immune suppression, home oxygen, medicines and ability to drink or self-isolate. A deterioration after initial recovery suggests secondary bacterial pneumonia or another complication. Ask about SARS-CoV-2 exposure and other respiratory viruses when circulating.
Examination
Measure temperature, respiratory rate, heart rate, blood pressure, oxygen saturation, hydration and mental state. Examine for increased work of breathing, cyanosis, focal chest signs, wheeze, crackles, dehydration, rash, meningism, heart failure and neurological deficit. Assess children for feeding, urine output, chest indrawing, grunting and lethargy. Normal chest examination early in illness does not exclude influenza; hypoxia, focal signs, altered mental state or haemodynamic instability changes the care setting.
Investigations
Influenza is often diagnosed clinically during active circulation, but molecular testing is useful in hospital, high-risk patients, outbreaks and when it changes isolation or treatment. WHO states that clinical differentiation from other respiratory viruses is difficult outside epidemic settings. NCDC category A illness generally does not require influenza testing, whereas more severe categories may. Test for SARS-CoV-2 and other pathogens according to local epidemiology. Obtain chest radiograph, blood gas, full blood count, renal function, cultures and inflammatory markers only when pneumonia, sepsis, hypoxia, complications or admission is suspected; do not delay indicated antivirals while waiting for a confirmatory test.
Differential Diagnosis
COVID-19, RSV, rhinovirus, adenovirus, parainfluenza and bacterial upper-respiratory infection can resemble influenza. Influenza's abrupt fever and myalgia pattern is helpful but not definitive. During low influenza activity, a clinical label becomes less reliable and testing has greater value. Co-infection is possible; one positive viral result does not exclude bacterial pneumonia, pulmonary embolism, heart failure or another cause of breathlessness.
Community-acquired pneumonia, acute asthma or COPD exacerbation, bronchiolitis, croup, tuberculosis and malaria or dengue with respiratory symptoms may be relevant depending on age, geography, season and examination. Focal crackles, pleuritic pain, severe hypoxia, shock, recurrent fever after improvement or lobar radiographic change raise concern for bacterial complications. Myocarditis, pericarditis, encephalitis, rhabdomyolysis and myositis are uncommon but important when chest pain, arrhythmia, weakness, dark urine, confusion or seizures occur.
In pregnancy, distinguish influenza from pulmonary oedema, pulmonary embolism, pre-eclampsia complications and bacterial pneumonia. In infants, sepsis must remain in the differential. An older patient with delirium may have influenza but also urinary infection, stroke, hypoglycaemia or drug toxicity. Differential diagnosis guides testing and escalation; it is not a reason to give broad antibiotics to every febrile cough. Treat confirmed bacterial infection according to local antimicrobial policy and isolate suspected transmissible respiratory infection using current facility precautions.
Management
For uncomplicated influenza in a low-risk person, provide fluids, rest, antipyretic advice, return precautions, and measures to reduce household spread. Avoid antibiotics unless bacterial infection is suspected or confirmed. WHO states most people recover without treatment within about a week. Explain that cough and fatigue can persist and that a new deterioration, dyspnoea or inability to drink needs review. Do not use aspirin in children with viral illness because of Reye syndrome risk.
Offer or start antivirals promptly for severe, progressive or hospitalised influenza and for high-risk people according to current national guidance. WHO advises antivirals as soon as possible for high-risk or severe illness. NCDC's revised protocol states that Category B and C patients should receive oseltamivir and that empiric therapy, preferably within 48 hours, should not be delayed pending testing. The benefit is greatest early, but severe or hospitalised cases may still warrant treatment beyond 48 hours under clinician direction. Dose and duration require age, weight, renal and clinical-status review.
Provide oxygen, fluids, bronchodilator therapy, antibiotics, critical care or obstetric care only for the relevant complication. Assess bacterial superinfection, asthma or COPD exacerbation, heart failure and sepsis. Use droplet and standard precautions according to local infection-control advice, advise home isolation while acutely ill, and protect high-risk household members. Notify and coordinate suspected clusters through local surveillance systems. Prevention is annual vaccine plus practical respiratory hygiene, not antivirals for every exposure or indiscriminate testing of mild disease.
Prescribing Information
Oseltamivir is an antiviral, not an antibiotic. NCDC's current clinical protocol names it as the recommended treatment and gives category, timing, renal and age-related considerations. Do not prescribe it automatically for every fever and cough: uncomplicated category A illness generally receives symptomatic care under NCDC screening guidance. Conversely, do not withhold indicated empiric therapy from a high-risk, severe or progressive patient while waiting for a test. Document onset, category, pregnancy, renal function, weight in children, ability to absorb oral medicine and local supply.
Common adverse effects include nausea and vomiting; taking a prescribed dose with food may help. Rare neuropsychiatric and hypersensitivity events require clinical review. Renal impairment needs dose adjustment according to the current product information or protocol. Infants, preterm babies, pregnancy, breastfeeding, immune suppression and critical illness need clinician-specific dosing and duration; do not copy a routine adult course into these groups. Longer treatment may be considered in severe lower-respiratory disease or immune compromise under specialist supervision.
Do not prescribe antibiotics for uncomplicated influenza merely to prevent pneumonia. If bacterial pneumonia, otitis, sinusitis or sepsis is clinically suspected, choose an antibiotic from current local stewardship guidance after obtaining appropriate cultures where feasible. Vaccine products, availability, strain composition and eligibility differ across seasons and jurisdictions; confirm current Indian recommendations, storage and contraindications. Inhaled antivirals and combination therapies have distinct contraindications and are not interchangeable with oral oseltamivir. Every prescription needs a review route for vomiting, breathlessness, rash or deterioration.
When to Refer
Urgently refer people with hypoxia, respiratory distress, cyanosis, altered consciousness, seizures, persistent chest pain, shock, severe dehydration, inability to maintain oral intake, suspected sepsis, acute heart failure, severe asthma or COPD exacerbation, or concern for pneumonia or acute respiratory distress syndrome. Children with poor feeding, chest indrawing, grunting, apnoea, lethargy or reduced urine need paediatric assessment. Do not wait for an influenza result before arranging emergency care for a physiologically unwell patient.
Seek early medical assessment for pregnancy, postpartum state, young children, older adults, immune-suppressed patients and people with significant chronic disease even if initial symptoms appear modest. Obstetric review is appropriate when fever or breathlessness occurs in pregnancy because maternal hypoxia and alternative cardiopulmonary diagnoses affect the fetus. Refer for specialist input when antiviral resistance is suspected, disease is prolonged in immune suppression, there is myocarditis, encephalopathy, rhabdomyolysis, recurrent admission or complex renal dosing.
In India, access to PCR, oxygen, oseltamivir, intensive care and specialist maternity services varies. Give patients a feasible named emergency route and state that local NCDC category and hospital protocols govern testing, isolation and antiviral access. Public-health referral is appropriate for school, hostel, hospital, care-home or workplace clusters and unexplained severe respiratory illness. Document onset, category, pregnancy status, risk factors, oxygenation, antivirals, vaccination and relevant contacts to assist both clinical handover and surveillance.
Red Flags
Emergency features include difficult or fast breathing, low oxygen saturation, blue lips, chest pain, confusion, collapse, seizures, persistent inability to drink, markedly reduced urine, severe weakness, hypotension or signs of sepsis. A patient who improves and then develops new high fever, focal chest pain, purulent sputum, hypoxia or shock may have secondary bacterial pneumonia. A severe viral illness can also trigger asthma, COPD, heart failure, myocardial infarction or stroke; do not attribute all deterioration to 'just flu'.
Pregnancy, early postpartum state, age under five, older age, immune suppression and chronic disease lower the threshold for assessment. In children, fast breathing, chest indrawing, grunting, poor feeding, no tears, lethargy or apnoea are urgent signs. In adults, acute confusion, new focal neurological symptoms, severe myalgia with dark urine, palpitations or syncope may represent encephalopathy, rhabdomyolysis, myocarditis or arrhythmia.
Medication red flags include repeated vomiting after oseltamivir preventing absorption, anaphylaxis, severe rash or neuropsychiatric change. Infection-control red flags include a cluster in a high-risk facility, unexplained severe acute respiratory illness, death, or a suspected novel influenza exposure; follow public-health protocols promptly. Do not encourage patients to repeatedly self-test or self-medicate while unstable. A clear safety-net specifies emergency transport, the nearest equipped facility and the need to bring medicine packets and a vaccination history.
Indian Clinical Context
India's NCDC publishes seasonal-influenza clinical categorisation, testing, home-care, mask, laboratory and vaccine resources. These documents are the relevant operational reference for local categories and are updated; this guide therefore does not reproduce a static national category table or promise current access in every state. NCDC's revised clinical protocol supports symptomatic management for uncomplicated Category A illness and oseltamivir for Category B and C patients, with empiric treatment not delayed when indicated. Local public or private hospitals may implement additional protocols.
Seasonality, surveillance capacity and vaccine supply are heterogeneous. Tropical circulation can be irregular, and current vaccine composition should be checked against NCDC and product information for the relevant season. Vaccination priorities, employer policies, private availability and reimbursement may differ. Do not state that a particular brand or vaccine formulation is universally available. Safe care also depends on oxygen, pulse oximetry, paediatric dosing support, renal monitoring and emergency transport, which are not equally accessible.
Explain uncertainty frankly. WHO global burden and international antiviral evidence do not establish exact Indian incidence or benefit in every population. Antibiotics must follow local antimicrobial guidance when bacterial infection is suspected; they are not influenza treatment. NMC education supports respiratory assessment, infection prevention, rational antiviral and antibiotic decisions, outbreak awareness and referral, while exact competency codes must be verified locally. This guide remains reviewed and has been reviewed by the MedNext Clinical Team.
NMC Competency Mapping
Influenza integrates medicine, paediatrics, microbiology, pharmacology, community medicine, emergency care and obstetrics. Learners should recognise influenza-like illness, identify high-risk groups, take an exposure and vaccination history, measure respiratory rate and oxygen saturation, differentiate uncomplicated disease from pneumonia or sepsis, and select an appropriate testing and isolation approach. They should understand that a clinical syndrome does not reliably distinguish influenza from all other respiratory viruses.
At Know and Know How level, students explain droplet transmission, annual vaccine rationale, complications, antiviral timing and why antibiotics do not treat uncomplicated influenza. At Show How level, they counsel on fluids, cough etiquette, home isolation, danger signs, safe antipyretic use and medicine adherence; use a local triage category; and refer hypoxic, pregnant or high-risk patients promptly. Antiviral dosing in infants, pregnancy, renal impairment and critical illness is supervised and must follow the current Indian protocol.
Assessment can use a febrile pregnant patient with cough and tachypnoea, asking for risk stratification, testing, empiric antiviral principle, differential and transfer. A second case of a healthy adult with mild illness tests stewardship and avoidance of unnecessary antibiotics. Professionalism includes addressing work absence, household crowding, vaccine hesitancy and limited access to testing without shame. Consult current NMC regulations and the institution's adopted curriculum for formal code-level mapping.
Key Exam Pearls for NEET PG
Influenza A and B cause seasonal epidemics; only influenza A viruses are known to cause pandemics. Incubation is about one to four days, typically around two. Abrupt fever, dry cough, sore throat, myalgia, headache and malaise are characteristic but not diagnostic. Clinical influenza-like illness overlaps with COVID-19, RSV and other viruses. Complications include viral or bacterial pneumonia, sepsis, ARDS, myocarditis, encephalopathy and worsening of chronic disease.
High-risk groups include pregnancy, children under five, older adults, chronic illness and immune suppression. Most low-risk uncomplicated illness receives fluids, rest, antipyretic care and safety-netting, not antibiotics. WHO and NCDC support early antiviral treatment for high-risk or severe illness; NCDC advises empiric oseltamivir for Category B and C patients without waiting for test confirmation when indicated. Renal function, age, weight and pregnancy affect prescribing.
Red flags are hypoxia, respiratory distress, cyanosis, shock, altered consciousness, seizures, inability to drink, reduced urine and deterioration after improvement. Annual vaccination is the best prevention because immunity wanes and viruses evolve. Hand hygiene, cough etiquette, ventilation and staying home while ill reduce transmission. Do not confuse viral treatment with bacterial stewardship: antibiotics are reserved for a suspected or confirmed bacterial complication and follow local policy.
Frequently Asked Questions
Does every person with influenza-like illness need oseltamivir?
No. NCDC screening guidance states that uncomplicated Category A illness generally receives symptomatic management and does not require oseltamivir. Antiviral treatment is important for Category B or C illness, severe or progressive disease, hospitalised patients and people at high risk, and should not be delayed for a confirmatory test when indicated. The clinician must use the current local category, onset, pregnancy status, age, weight and renal function.
Are antibiotics useful to prevent pneumonia in uncomplicated influenza?
No. Antibiotics do not treat influenza and should not be used merely to prevent bacterial pneumonia. They are indicated only when bacterial co-infection or another bacterial diagnosis is suspected or confirmed. New focal chest signs, recurrent fever after improvement, hypoxia, shock or severe deterioration need clinical assessment and possibly antibiotics selected under local antimicrobial guidance.
Can a pregnant person receive influenza antiviral treatment?
Pregnancy is a high-risk state for severe influenza, so prompt medical assessment and antiviral treatment when indicated are important. NCDC notes increased risk in pregnancy and advises multidisciplinary management of complications. Drug choice, timing, renal function, vomiting and obstetric symptoms require clinician review; this guide does not substitute a pregnancy-specific dose or monitoring plan.
Why is influenza vaccination repeated every year?
Influenza viruses evolve and immunity decreases over time. WHO recommends annual vaccination and updates recommended vaccine composition for different seasons and hemispheres through global surveillance. The exact product and schedule available in India change with season, supply and local policy, so patients should confirm the current recommendation with their clinician or authorised public-health source.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic